Chimerix Inc (CMRX)
0.9818
-0.02
(-1.82%)
USD |
NASDAQ |
May 15, 14:27
Chimerix Accounts Receivable (Quarterly): 0.001M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.001M |
December 31, 2023 | 0.004M |
September 30, 2023 | 0.011M |
June 30, 2023 | 0.026M |
March 31, 2023 | 0.668M |
December 31, 2022 | 1.04M |
September 30, 2022 | 0.468M |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.053M |
June 30, 2021 | 0.036M |
March 31, 2021 | 0.482M |
December 31, 2020 | 0.34M |
September 30, 2020 | 0.378M |
June 30, 2020 | 0.367M |
March 31, 2020 | 1.079M |
December 31, 2019 | 1.233M |
September 30, 2019 | 1.822M |
June 30, 2019 | 0.774M |
March 31, 2019 | 1.425M |
December 31, 2018 | 0.33M |
September 30, 2018 | 0.332M |
Date | Value |
---|---|
June 30, 2018 | 0.219M |
March 31, 2018 | 0.426M |
December 31, 2017 | 1.682M |
September 30, 2017 | 0.27M |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.811M |
December 31, 2016 | 1.599M |
September 30, 2016 | 0.379M |
June 30, 2016 | 0.313M |
March 31, 2016 | 0.566M |
December 31, 2015 | 2.432M |
September 30, 2015 | 0.525M |
June 30, 2015 | 2.311M |
March 31, 2015 | 0.977M |
December 31, 2014 | 0.106M |
September 30, 2014 | 0.902M |
June 30, 2014 | 0.288M |
March 31, 2014 | 0.089M |
December 31, 2013 | 0.248M |
September 30, 2013 | 0.19M |
June 30, 2013 | 0.083M |
March 31, 2013 | 1.228M |
December 31, 2012 | 0.783M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
1.822M
Maximum
Sep 2019
0.4879M
Average
0.3725M
Median
Accounts Receivable (Quarterly) Benchmarks
UFP Technologies Inc | 61.25M |
Dentsply Sirona Inc | 656.00M |
Arbutus Biopharma Corp | 2.139M |
Pacira BioSciences Inc | 101.64M |
Karyopharm Therapeutics Inc | 31.08M |